Andresen F, Yoshimi A, Bader P, Bierings M, Bod'ová I, Bordon V, Buechner J, Burkhardt B, Dworzak M, Erlacher M, Kállay K, Labarque V, Locatelli F, Malone A, Masmas T, Müller I, Nöllke P, Schmugge M, Pawelec K, Sedlacek P, Sevilla J, Smith O, Stary J, Niemeyer C, Strahm B (2026)
Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years
Blood Adv, 10 (6), 1992-2005
DOI 10.1182/bloodadvances.2025018285, PubMed 41558034
Ben Hassine K, Gloor Y, Dupanloup I, Uppugunduri CRS, Mlakar V, Gonzales F, Güngör T, Ifversen M, Shaw PJ, Buechner J, Truong TH, Bittencourt H, Teague L, Toporski J, Sedlacek P, Poetschger U, Krajinovic M, Kałwak K, Balduzzi A, Algeri M, Bader P, Peters C, Dalle JH, Ansari M (2026)
Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study
Blood Adv, 10 (10), 3719-3730
DOI 10.1182/bloodadvances.2025019142, PubMed 41779961
Buechner J, Poetschger U, Bader P, Yeşilipek A, Pichler H, Palma J, Staciuk R, Riha P, Kriván G, Ifversen M, Güngör T, Goussetis E, Kalwak K, Toporski J, Gabriel M, Renard M, Diaz-de-Heredia C, Matic T, Calkoen FG, Svec P, Meisel R, Balduzzi A, Locatelli F, Peters C, Dalle JH, Stein J (2026)
Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study
Blood, 147 (12), 1365-1379
DOI 10.1182/blood.2025030951, PubMed 41259231
Grupp SA, Maude SL, Rives S, Hiramatsu H, Baruchel A, Bader P, Bittencourt H, Buechner J, Laetsch TW, De Moerloose B, Qayed M, Stefanski HE, Davis KL, Driscoll TA, Nemecek E, Peters C, Yanik G, Balduzzi A, Boissel N, Khaw SL, Krueger J, Levine JE, Myers GD, Tiwari R, O'Donovan D, Awasthi R, Ramos R, Willert J, Pulsipher MA (2026)
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL
J Clin Oncol, JCO2501471 (in press)
DOI 10.1200/JCO-25-01471, PubMed 42525896
Iannicelli A, Locatelli F, Jiang Y, Ammerlaan A, Rives S, van der Sluis IM, Lindemans C, Bielorai B, Díaz de Heredia C, Lissat A, Rossig C, Petit A, Rialland Battisti F, Rizzari C, Nilsson AB, Bruno B, Rubio San Simón A, Sramkova L, Engstler G, Dirksen U, Brethon B, De Moerloose B, Pasquet M, McCarthy P, Nysom K, Halfon-Domenech C, Bertorello N, Buechner J, Bader P, Zwaan CM et al. (2026)
Sinusoidal obstruction syndrome in children with B-acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin: Results from the ITCC-059 trial
Hemasphere, 10 (8), e70448
DOI 10.1002/hem3.70448, PubMed 42631095
Kvammen JA, Thomassen RA, Godang K, Buechner J, Bollerslev J, Bentsen BS, Bechensteen AG, Henriksen C (2026)
Body Composition, Bone Health, and Dietary Intake in Children After Allogeneic Hematopoietic Stem Cell Transplantation
Nutrients, 18 (13)
DOI 10.3390/nu18132193, PubMed 42451193
Moser LM, Hutter M, Ahlmann M, Alonso-Saladrigues A, Attarbaschi A, Ayuk FA, Baldus CD, Balduzzi A, Bonig H, Bourquin JP, Buechner J, Buecklein VL, Burridge S, Calkoen FG, Cario G, De Moerloose B, de Oliveira Canedo G, Dourthe ME, Feuchtinger T, Füreder A, Hauer J, Ifversen M, Jarisch A, Kalwak K, Klusmann JH, Kobbe G, Koenecke C, Künkele A, Meisel R, Merli P et al. (2026)
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Leukemia (in press)
DOI 10.1038/s41375-026-03105-y, PubMed 42675139
Nademi Z, Lum SH, Gilbert P, Sirait T, Karakukcu M, Locatelli F, Schulz A, Gozdzik J, Ikinciogullari A, Kalwak K, Alsaedi H, Bierings M, Bader P, Diaz de Heredia C, Winiarski J, Masmas TN, Lankester AC, Gabriel M, Biffi A, Mitchell R, Ryhänen S, Kuskonmaz B, Corbacioglu S, Faraci M, Buechner J, Kerre T, Kulagin A, Lewalle P, Ghosh S, Schlegel PG et al. (2026)
Outcome of second conditioned allogeneic stem cell transplant in children with non-SCID inborn errors of immunity
Blood Adv, 10 (9), 3207-3217
DOI 10.1182/bloodadvances.2025015971, PubMed 41774850
Peccatori N, Locatelli F, Ammerlaan ACJ, Jiang Y, van der Velden VHJ, Lissat A, Nilsson A, Bielorai B, Moerloose B, Rives S, Rubio-San-Simon A, Dirksen U, Engstler G, Bruno B, Diaz-de-Heredia C, Brethon B, Sirvent FB, Rialland F, Sramkova L, Pasquet M, Nysom K, Bertorello N, Bader P, Buechner J, van der Sluis IM, Beverloo B, Sleight B, Stackelberg AV, Zwaan CM, Brivio E (2026)
Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial
Lancet Haematol, 13 (7), e449-e459
DOI 10.1016/S2352-3026(26)00104-3, PubMed 42296977
Quagliarella F, Becci M, Buechner J, Becilli M, Zecca M, Bernardo ME, Lucchini G, Masetti R, Perdichizzi S, Faraci M, Tumino M, Fagioli F, Cefalo MG, Heier I, Boccieri E, Andreani M, Pagliara D, Locatelli F, Algeri M, Merli P (2026)
Abatacept in combination with ATLG reduces acute GvHD incidence and improves outcomes of children transplanted from mismatched unrelated donors: a real-world, multicenter, retrospective study
Transplant Cell Ther (in press)
DOI 10.1016/j.jtct.2026.10.009, PubMed 42855012
Vepsälainen K, Allen CE, Becker S, Buechner J, Goyal G, Antti K, Tyrväinen E, Ryhänen S, Jokelainen O (2026)
Transdifferentiation of Pediatric Pre-B-ALL Into Histiocytic Sarcoma Harboring BRAF and FLT3 Mutations: Durable Remission With MEK Inhibition, Surgery, and Allogeneic Stem Cell Transplantation
Pediatr Blood Cancer, 73 (9), e70473
DOI 10.1002/1545-5017.70473, PubMed 42527376
Balduzzi A, Glogova E, Peters C, Sedlacek P, Dalle JH, Locatelli F, Meisel R, Burkhardt B, Buechner J, Wachowiak J, Bierings M, Staciuk R, Graphakos S, Güngör T, Yesilipek A, Svec P, Palma J, Krivan G, Diaz-de-Heredia C, Limido F, Ansari M, Kalwak K, Bader P, Ifversen M (2025)
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial
Haematologica, 111 (1), 122-134
DOI 10.3324/haematol.2025.287456, PubMed 40820816
Baruchel A, Nysom K, Kang HJ, Felice MS, Michalowski MB, Freigeiro D, Epelman S, Lopes de Sousa AV, Valera ET, Moreira L, Leverger G, Nelken B, Kattamis A, Rizzari C, Fagioli F, Cesaro S, González-Llano O, Buechner J, Choque WQ, Duarte J, Abrahamsson J, Alarcón A, Wang L, Macé S, Oprea C, Abbadessa G, Zwaan CM (2025)
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
Hemasphere, 9 (10), e70245
DOI 10.1002/hem3.70245, PubMed 41180900
Deimundo Roura C, Amrolia P, Ansari M, Bader P, Balduzzi A, Buechner J, Hsieh EM, Myers RM, Ottaviano G, Peters C, Rouce RH, Shah NN, Verneris MR, Kalwak K, Pulsipher MA (2025)
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group
Transplant Cell Ther, 32 (3), 261-276
DOI 10.1016/j.jtct.2025.10.023, PubMed 41176033
Ghanjati F, Heck A, Lebrecht D, Nöllke P, Andresen F, Rotari N, Schoof M, Schönung M, Lipka DB, Dworzak M, De Moerloose B, Sukova M, Hasle H, Jahnukainen K, Malone A, Masetti R, Buechner J, Ussowicz M, Catala A, Turkiewicz D, de Haas V, Schmugge M, Erlacher M, Niemeyer CM, Flotho C (2025)
Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus
Clin Epigenetics, 17 (1), 154
DOI 10.1186/s13148-025-01983-0, PubMed 41044657
Hammoudi T, Nucera S, Troullioud Lucas AG, Ansari M, Balduzzi A, Bertaina A, Buechner J, Corbacioglu S, Dalle JH, Kalwak K, Lee D, Levine JE, Lindemans CA, Locatelli F, Meisel R, Nierkens S, Ottaviano G, Perez-Martinez A, Pichler H, Prockop SE, Pulsipher MA, Talano JM, Tewari S, Schultz KR, Shah NN, Verneris MR, Boelens JJ (2025)
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group
Blood Adv, 9 (23), 6141-6157
DOI 10.1182/bloodadvances.2025016915, PubMed 40902074
Ince E, Galimard JE, Ifversen M, Dalissier A, Szmit Z, Mirci-Danicar O, Locatelli F, Sedlacek P, Styczynski J, Dalle JH, Renard C, Balduzzi A, Lankester A, Bierings M, Fagioli F, Kielsen K, Rialland F, Buechner J, Taskinen M, Wynn R, Jubert C, Michel G, Pichler H, Krivan G, Cesaro S, Corbacioglu S, Meisel R, Kalwak K (2025)
Erratum to: "Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study"
Haematologica, 110 (11), 2871-2872
DOI 10.3324/haematol.2025.288047, PubMed 41178440
Kalwak K, Moser LM, Pötschger U, Bader P, Kleinschmidt K, Meisel R, Dalle JH, Yesilipek A, Balduzzi A, Krivan G, Goussetis E, Staciuk R, Sedlacek P, Pichler H, Svec P, Gabriel M, Güngör T, Bilic E, Buechner J, Renard M, Vettenranta K, Ifversen M, Diaz-de-Heredia C, Stein J, Toporski J, Bierings M, Peters C, Ansari M, Locatelli F (2025)
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
Blood Adv, 9 (4), 741-751
DOI 10.1182/bloodadvances.2024014548, PubMed 39602342
Kotmayer L, Kozyra EJ, Kang G, Strahm B, Yoshimi A, Sahoo SS, Pastor VB, Attardi E, Voss R, Vinci L, Kaiser M, Dworzak MN, De Moerloose B, Sukova M, Starý J, Hasle H, Jahnukainen K, Polychronopoulou S, Kállay K, Smith OP, Malone A, Barzilai Birenboim S, Masetti R, Buechner J, Ussowicz M, Kjöllerström P, Bodova I, Kavcic M, Català A, Turkiewicz D et al. (2025)
Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency
Blood Cancer J, 15 (1), 121
DOI 10.1038/s41408-025-01309-6, PubMed 40664679
Kvammen JA, Thomassen RA, Buechner J, Myklebust TÅ, Thorsby PM, Bollerslev J, Bentsen BS, Bechensteen AG, Henriksen C (2025)
Vitamin D status in children undergoing allogeneic hematopoietic stem cell transplantation: A prospective exploratory study
J Pediatr Gastroenterol Nutr, 80 (6), 1007-1017
DOI 10.1002/jpn3.70028, PubMed 40123471
Pearson ADJ, Rossig C, Mackall CL, Shah NN, Baruchel A, Daems S, Anderson J, Biondi A, Bird N, Bodmer N, Brivio E, Buechner J, Calkoen FG, Cooper T, de Rojas T, Fox E, Gardner R, Ghorashian S, Heenen D, Ifversen M, Jacoby E, Juan M, Knox L, Komanduri K, Larghero J, Locatelli F, Ludwinski D, Majzner RG, McDonough J, Minard-Colin V et al. (2025)
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Lancet Oncol, 26 (4), e214-e224
DOI 10.1016/S1470-2045(24)00736-8, PubMed 40179917
Riller Q, Hauri M, Lum SH, Knippenberg J, Sirait T, Laberko A, Halahleh K, Hashem H, Karakukcu M, Sengeloev H, Porta F, Bruno B, Zecca M, Aksoylar S, Barlogis V, Schuetz C, Buechner J, Faraci M, Wehr C, Holter W, Mellgren K, Locatelli F, Martinez AP, Suarez F, Moshous D, Gennery AR, Balashov D, Albert MH, Slatter M, Güngör T et al. (2025)
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study
Blood, 145 (21), 2518-2527
DOI 10.1182/blood.2024026915, PubMed 40090009
Zeckanovic A, Mouttet B, Vinti L, Ancliff P, Brethon B, Cario G, Elitzur S, Hazar V, Kunz J, Möricke A, Stein J, Yaman Y, Buechner J, Hjort MA, O'Connor D, Hodder A, Bartram J, Alten J, Barbaric D, Escherich G, Boissel N, Vasseur L, Clappier E, Farnault L, Bonnet S, Patrick K, Schrappe M, Anak S, Baruchel A, Locatelli F et al. (2025)
Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation
Haematologica, 110 (6), 1373-1378
DOI 10.3324/haematol.2024.286111, PubMed 39911115
Bader P, Pötschger U, Dalle JH, Moser LM, Balduzzi A, Ansari M, Buechner J, Güngör T, Ifversen M, Krivan G, Pichler H, Renard M, Staciuk R, Sedlacek P, Stein J, Heusel JR, Truong T, Wachowiak J, Yesilipek A, Locatelli F, Peters C (2024)
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study
Blood Adv, 8 (2), 416-428
DOI 10.1182/bloodadvances.2023010591, PubMed 37738088
Chonat S, Kulagin A, Maschan A, Bartels M, Buechner J, Punzalan R, Richards M, Ogawa M, Hicks E, Yu J, Baruchel A, Kulasekararaj AG (2024)
Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria
Blood Adv, 8 (11), 2813-2824
DOI 10.1182/bloodadvances.2023012267, PubMed 38551806
Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
Epigenetic aging of human blood cells is influenced by the age of the host body
Aging Cell, 23 (5), e14112
DOI 10.1111/acel.14112, PubMed 38439206
Ince E, Galimard JE, Ifversen M, Dalissier A, Szmit Z, Mirci-Danicar O, Locatelli F, Sedlacek P, Styczynski J, Dalle JH, Renard C, Balduzzi A, Lankester A, Bierings M, Fagioli F, Kielsen K, Rialland F, Büchner J, Taskinen M, Wynn R, Jubert C, Michel G, Pichler H, Krivan G, Cesaro S, Corbacioglu S, Meisel R, Kalwak K (2024)
Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study
Haematologica, 110 (4), 985-989
DOI 10.3324/haematol.2024.286082, PubMed 39605204
Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
Ther Drug Monit, 46 (3), 416-417
DOI 10.1097/FTD.0000000000001209, PubMed 38648662
Yoshimi A, Noellke P, Starý J, Kállay K, Smith O, Locatelli F, Buechner J, Bodova I, Sevilla J, Schmugge M, Bierings M, Masmas T, Dworzak M, Labarque V, Pawelec K, Jahnukainen K, Polychronopoulou S, Kjollerstrom P, Kavcic M, Erlacher M, Niemeyer CM, Strahm B (2024)
Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine a in children with acquired severe aplastic anemia
Am J Hematol, 99 (7), 1403-1406
DOI 10.1002/ajh.27334, PubMed 38622880
Ramamoorthy S, Lebrecht D, Schanze D, Schanze I, Wieland I, Andrieux G, Metzger P, Hess M, Albert MH, Borkhardt A, Bresters D, Buechner J, Catala A, De Haas V, Dworzak M, Erlacher M, Hasle H, Jahnukainen K, Locatelli F, Masetti R, Stary J, Turkiewicz D, Vinci L, Wlodarski MW, Yoshimi A, Boerries M, Niemeyer CM, Zenker M, Flotho C (2023)
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup
Br J Haematol, 204 (2), 595-605
DOI 10.1111/bjh.19190, PubMed 37945316
Vinci L, Flotho C, Noellke P, Lebrecht D, Masetti R, de Haas V, De Moerloose B, Dworzak M, Hasle H, Güngör T, Starý J, Turkiewicz D, Ussowicz M, de Heredia CD, Buechner J, Jahnukainen K, Kallay K, Bodova I, Smith OP, Zecca M, Bresters D, Lang P, Masmas TN, Meisel R, Pichler H, Erlacher M, Göhring G, Locatelli F, Strahm B, Niemeyer CM et al. (2023)
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Bone Marrow Transplant, 58 (5), 607-609
DOI 10.1038/s41409-023-01942-4, PubMed 36823455
Balduzzi A, Buechner J, Ifversen M, Dalle JH, Colita AM, Bierings M (2022)
Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
Front Pediatr, 10, 807992
DOI 10.3389/fped.2022.807992, PubMed 35281233
Buechner J, Caruana I, Künkele A, Rives S, Vettenranta K, Bader P, Peters C, Baruchel A, Calkoen FG (2022)
Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?
Front Pediatr, 9, 784024
DOI 10.3389/fped.2021.784024, PubMed 35145941
Calvo C, Ronceray L, Dhédin N, Buechner J, Troeger A, Dalle JH (2022)
Haematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukaemia: Special Considerations and Challenges
Front Pediatr, 9, 796426
DOI 10.3389/fped.2021.796426, PubMed 35087777
Jacoby E, Ghorashian S, Vormoor B, De Moerloose B, Bodmer N, Molostova O, Yanir AD, Buechner J, Elhasid R, Bielorai B, Rogosic S, Dourthe ME, Maschan M, Rossig C, Toren A, von Stackelberg A, Locatelli F, Bader P, Zimmermann M, Bourquin JP, Baruchel A (2022)
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study
Leukemia, 36 (6), 1525-1532
DOI 10.1038/s41375-022-01546-9, PubMed 35468946
Kállay KM, Algeri M, Buechner J, Krauss AC (2022)
Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL?
Front Pediatr, 9, 795833
DOI 10.3389/fped.2021.795833, PubMed 35252074
Kvammen JA, Thomassen RA, Buechner J, Sitsabesan A, Bentsen BS, Bechensteen AG, Henriksen C (2022)
Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Nutritional Status and Intake in Children
J Pediatr Gastroenterol Nutr, 75 (5), 675-682
DOI 10.1097/MPG.0000000000003592, PubMed 35994021
Laetsch TW, Maude SL, Balduzzi A, Rives S, Bittencourt H, Boyer MW, Buechner J, De Moerloose B, Qayed M, Phillips CL, Pulsipher MA, Hiramatsu H, Tiwari R, Grupp SA (2022)
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
Leukemia, 36 (6), 1508-1515
DOI 10.1038/s41375-022-01550-z, PubMed 35422096
Laetsch TW, Maude SL, Rives S, Hiramatsu H, Bittencourt H, Bader P, Baruchel A, Boyer M, De Moerloose B, Qayed M, Buechner J, Pulsipher MA, Myers GD, Stefanski HE, Martin PL, Nemecek E, Peters C, Yanik G, Khaw SL, Davis KL, Krueger J, Balduzzi A, Boissel N, Tiwari R, O'Donovan D, Grupp SA (2022)
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
J Clin Oncol, 41 (9), 1664-1669
DOI 10.1200/JCO.22.00642, PubMed 36399695
Svec P, Elfeky R, Galimard JE, Higham CS, Dalissier A, Quigg TC, Bueno Sanchez D, Han Lum S, Faraci M, Cole T, Pichler H, Benítez-Carabante MI, Horakova J, Gonzalez-Vicent M, Yanir A, Fagioli F, Wölfl M, von der Weid N, Protheroe R, Krivan G, Speckmann C, James B, Avcin SL, Bertrand Y, Verna M, Riha P, Patrick K, Cesaro S, Kalwak K, Bierings M et al. (2022)
Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study
Bone Marrow Transplant, 58 (2), 129-141
DOI 10.1038/s41409-022-01852-x, PubMed 36333550
Vettenranta K, Dobšinská V, Kertész G, Svec P, Buechner J, Schultz KR (2022)
What Is the Role of HSCT in Philadelphia-Chromosome-Positive and Philadelphia-Chromosome-Like ALL in the Tyrosine Kinase Inhibitor Era?
Front Pediatr, 9, 807002
DOI 10.3389/fped.2021.807002, PubMed 35186828
Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT, Buechner J, Garcia KC, Schumacher TN, van Veelen PA, Leisegang M et al. (2021)
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
Nat Biotechnol, 40 (4), 488-498
DOI 10.1038/s41587-021-01089-x, PubMed 34873326
Andersen AM, Bergan S, Gedde-Dahl T, Buechner J, Vethe NT (2021)
Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients
J Pharm Biomed Anal, 203, 114216
DOI 10.1016/j.jpba.2021.114216, PubMed 34182411
Balduzzi A, Bönig H, Jarisch A, Nava T, Ansari M, Cattoni A, Prunotto G, Lucchini G, Krivan G, Matic T, Kalwak K, Yesilipek A, Ifversen M, Svec P, Buechner J, Vettenranta K, Meisel R, Lawitschka A, Peters C, Gibson B, Dalissier A, Corbacioglu S, Willasch A, Dalle JH, Bader P, EBMT Pediatric Diseases Working Party (2021)
Correction: ABO incompatibile graft management in pediatric transplantation
Bone Marrow Transplant, 56 (1), 297
DOI 10.1038/s41409-020-01012-z, PubMed 32753704
Buechner J, Grupp SA, Hiramatsu H, Teachey DT, Rives S, Laetsch TW, Yanik GA, Wood P, Awasthi R, Yi L, Chassot-Agostinho A, Eldjerou LK, De Moerloose B (2021)
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy
Blood Adv, 5 (2), 593-601
DOI 10.1182/bloodadvances.2020002757, PubMed 33496754
Burkhardt B, Taj M, Garnier N, Minard-Colin V, Hazar V, Mellgren K, Osumi T, Fedorova A, Myakova N, Verdu-Amoros J, Andres M, Kabickova E, Attarbaschi A, Chiang AKS, Bubanska E, Donska S, Hjalgrim LL, Wachowiak J, Pieczonka A, Uyttebroeck A, Lazic J, Loeffen J, Buechner J, Niggli F, Csoka M, Krivan G, Palma J, Burke GAA, Beishuizen A, Koeppen K et al. (2021)
Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
Cancers (Basel), 13 (9)
DOI 10.3390/cancers13092075, PubMed 33923026
Ifversen M, Meisel R, Sedlacek P, Kalwak K, Sisinni L, Hutt D, Lehrnbecher T, Balduzzi A, Diesch T, Jarisch A, Güngör T, Stein J, Yaniv I, Bonig H, Kuhlen M, Ansari M, Nava T, Dalle JH, Diaz-de-Heredia C, Trigoso E, Falkenberg U, Hartmann M, Deiana M, Canesi M, Broggi C, Bertaina A, Gibson B, Krivan G, Vettenranta K, Matic T et al. (2021)
Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Front Pediatr, 9, 705179
DOI 10.3389/fped.2021.705179, PubMed 34395344
Jørgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla ØL, Lundman E, Alme C, Heier I, Flægstad T, Fløisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordøy I (2021)
A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
J Clin Immunol, 42 (2), 404-420
DOI 10.1007/s10875-021-01189-y, PubMed 34893945
Kozyra EJ, Göhring G, Hickstein DD, Calvo KR, DiNardo CD, Dworzak M, de Haas V, Starý J, Hasle H, Shimamura A, Fleming MD, Inaba H, Lewis S, Hsu AP, Holland SM, Arnold DE, Mecucci C, Keel SB, Bertuch AA, Tawana K, Barzilai S, Hirabayashi S, Onozawa M, Lei S, Alaiz H, Andrikovics H, Betts D, Beverloo BH, Buechner J, Čermák M et al. (2021)
Association of unbalanced translocation der(1;7) with germline GATA2 mutations
Blood, 138 (23), 2441-2445
DOI 10.1182/blood.2021012781, PubMed 34469508
Levine JE, Grupp SA, Pulsipher MA, Dietz AC, Rives S, Myers GD, August KJ, Verneris MR, Buechner J, Laetsch TW, Bittencourt H, Baruchel A, Boyer MW, De Moerloose B, Qayed M, Davies SM, Phillips CL, Driscoll TA, Bader P, Schlis K, Wood PA, Mody R, Yi L, Leung M, Eldjerou LK, June CH, Maude SL (2021)
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
J Immunother Cancer, 9 (8)
DOI 10.1136/jitc-2020-002287, PubMed 34353848
Merli P, Ifversen M, Truong TH, Marquart HV, Buechner J, Wölfl M, Bader P (2021)
Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?
Front Pediatr, 9, 777108
DOI 10.3389/fped.2021.777108, PubMed 34805054
Panagopoulos I, Andersen K, Eilert-Olsen M, Zeller B, Munthe-Kaas MC, Buechner J, Osnes LTN, Micci F, Heim S (2021)
Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3
Cancer Genomics Proteomics, 18 (1), 67-81
DOI 10.21873/cgp.20242, PubMed 33419897
Pulsipher MA, Han X, Maude SL, Laetsch TW, Qayed M, Rives S, Boyer MW, Hiramatsu H, Yanik GA, Driscoll T, Myers GD, Bader P, Baruchel A, Buechner J, Stefanski HE, Kalfoglou C, Nguyen K, Waldron ER, Thudium Mueller K, Maier HJ, Kari G, Grupp SA (2021)
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
Blood Cancer Discov, 3 (1), 66-81
DOI 10.1158/2643-3230.BCD-21-0095, PubMed 35019853
Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, Noellke P, Dworzak M, Starý J, Locatelli F, Masetti R, Schmugge M, De Moerloose B, Catala A, Kállay K, Turkiewicz D, Hasle H, Buechner J, Jahnukainen K, Ussowicz M, Polychronopoulou S, Smith OP, Fabri O, Barzilai S, de Haas V, Baumann I, Schwarz-Furlan S, European Working Group of MDS in Children (EWOG-MDS), Niewisch MR, Sauer MG et al. (2021)
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Nat Med, 27 (10), 1806-1817
DOI 10.1038/s41591-021-01511-6, PubMed 34621053
Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, Noellke P, Dworzak M, Starý J, Locatelli F, Masetti R, Schmugge M, De Moerloose B, Catala A, Kállay K, Turkiewicz D, Hasle H, Buechner J, Jahnukainen K, Ussowicz M, Polychronopoulou S, Smith OP, Fabri O, Barzilai S, de Haas V, Baumann I, Schwarz-Furlan S, European Working Group of MDS in Children (EWOG-MDS), Niewisch MR, Sauer MG et al. (2021)
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Nat Med, 27 (12), 2248
DOI 10.1038/s41591-021-01632-y, PubMed 34799732
Truong TH, Jinca C, Mann G, Arghirescu S, Buechner J, Merli P, Whitlock JA (2021)
Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
Front Pediatr, 9, 782785
DOI 10.3389/fped.2021.782785, PubMed 35004545
Willasch AM, Peters C, Sedláček P, Dalle JH, Kitra-Roussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Kriván G, Hamladji RM, Diaz-de-Heredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, Veys P, Dupont S, Or R, Güngör T, Aleinikova O, Sufliarska S, Sundin M, Rascon J, Kaare A, Nemet D, Fagioli F et al. (2021)
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study
Bone Marrow Transplant, 56 (10), 2615
DOI 10.1038/s41409-021-01424-5, PubMed 34413474
Balduzzi A, Bönig H, Jarisch A, Nava T, Ansari M, Cattoni A, Prunotto G, Lucchini G, Krivan G, Matic T, Kalwak K, Yesilipek A, Ifversen M, Svec P, Buechner J, Vettenranta K, Meisel R, Lawitschka A, Peters C, Gibson B, Dalissier A, Corbacioglu S, Willasch A, Dalle JH, Bader P, EBMT Pediatric Diseases Working Party (2020)
ABO incompatibile graft management in pediatric transplantation
Bone Marrow Transplant, 56 (1), 84-90
DOI 10.1038/s41409-020-0981-7, PubMed 32594103
Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, Falkenberg U, Bertaina A, Gibson B, Jarisch A, Balduzzi A, Boenig H, Krivan G, Vettenranta K, Matic T, Buechner J, Kalwak K, Lawitschka A, Yesilipek A, Lucchini G, Peters C, Turkiewicz D, Niinimäki R, Diesch T, Lehrnbecher T, Sedlacek P, Hutt D, Dalissier A, Wachowiak J, Yaniv I et al. (2020)
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant, 55 (6), 1126-1136
DOI 10.1038/s41409-020-0818-4, PubMed 32029909
Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, Falkenberg U, Bertaina A, Gibson B, Jarisch A, Balduzzi A, Boenig H, Krivan G, Vettenranta K, Matic T, Buechner J, Kalwak K, Lawitschka A, Yesilipek A, Lucchini G, Peters C, Turkiewicz D, Niinimäki R, Diesch T, Lehrnbecher T, Sedlacek P, Hutt D, Dalissier A, Wachowiak J, Yaniv I et al. (2020)
Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant, 55 (6), 1214
DOI 10.1038/s41409-020-0838-0, PubMed 32080355
Peters C, Dalle JH, Locatelli F, Poetschger U, Sedlacek P, Buechner J, Shaw PJ, Staciuk R, Ifversen M, Pichler H, Vettenranta K, Svec P, Aleinikova O, Stein J, Güngör T, Toporski J, Truong TH, Diaz-de-Heredia C, Bierings M, Ariffin H, Essa M, Burkhardt B, Schultz K, Meisel R, Lankester A, Ansari M, Schrappe M, IBFM Study Group;, von Stackelberg A, IntReALL Study Group et al. (2020)
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
J Clin Oncol, 39 (4), 295-307
DOI 10.1200/JCO.20.02529, PubMed 33332189
Strand J, Gul KA, Erichsen HC, Lundman E, Berge MC, Trømborg AK, Sørgjerd LK, Ytre-Arne M, Hogner S, Halsne R, Gaup HJ, Osnes LT, Kro GAB, Sorte HS, Mørkrid L, Rowe AD, Tangeraas T, Jørgensen JV, Alme C, Bjørndalen TEH, Rønnestad AE, Lang AM, Rootwelt T, Buechner J, Øverland T, Abrahamsen TG, Pettersen RD, Stray-Pedersen A (2020)
Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
Front Immunol, 11, 1417
DOI 10.3389/fimmu.2020.01417, PubMed 32754152
Willasch AM, Peters C, Sedláček P, Dalle JH, Kitra-Roussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Kriván G, Hamladji RM, Diaz-de-Heredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, Veys P, Dupont S, Or R, Güngör T, Aleinikova O, Sufliarska S, Sundin M, Rascon J, Kaare A, Nemet D, Fagioli F et al. (2020)
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study
Bone Marrow Transplant, 55 (8), 1540-1551
DOI 10.1038/s41409-020-0854-0, PubMed 32203263
Wolska-Kusnierz B, Pastorczak A, Fendler W, Wakulinska A, Dembowska-Baginska B, Heropolitanska-Pliszka E, Piątosa B, Pietrucha B, Kałwak K, Ussowicz M, Pieczonka A, Drabko K, Lejman M, Koltan S, Gozdzik J, Styczynski J, Fedorova A, Miakova N, Deripapa E, Kostyuchenko L, Krenova Z, Hlavackova E, Gennery AR, Sykora KW, Ghosh S, Albert MH, Balashov D, Eapen M, Svec P, Seidel MG et al. (2020)
Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
Clin Cancer Res, 27 (2), 575-584
DOI 10.1158/1078-0432.CCR-20-2574, PubMed 33082212
Bonig H, Kuçi Z, Kuçi S, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, Teichert von Luettichau I, Herter-Sprie G, Ashab Uddin M, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J, Salzmann-Manrique E, Hutter M, Schäfer R, Seifried E, Paneesha S et al. (2019)
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients
Cells, 8 (12)
DOI 10.3390/cells8121577, PubMed 31817480
Ifversen M, Turkiewicz D, Marquart HV, Winiarski J, Buechner J, Mellgren K, Arvidson J, Rascon J, Körgvee LT, Madsen HO, Abrahamsson J, Lund B, Jonsson OG, Heilmann C, Heyman M, Schmiegelow K, Vettenranta K (2019)
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
Br J Haematol, 184 (6), 982-993
DOI 10.1111/bjh.15761, PubMed 30680711
Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, De Moerloose B, Davis KL, Nemecek E, Driscoll T, Mechinaud F, Boissel N, Rives S, Bader P, Peters C, Sabnis HS, Grupp SA, Yanik GA, Hiramatsu H, Stefanski HE, Rasouliyan L, Yi L, Shah S, Zhang J, Harris AC (2019)
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial
Lancet Oncol, 20 (12), 1710-1718
DOI 10.1016/S1470-2045(19)30493-0, PubMed 31606419
Pearson ADJ, Scobie N, Norga K, Ligas F, Chiodin D, Burke A, Minard-Colin V, Adamson P, Marshall LV, Balakumaran A, Benettaib B, Bhargava P, Bollard CM, Bolotin E, Bomken S, Buechner J, Burkhardt B, Caron H, Copland C, Demolis P, Egorov A, Farhan M, Zugmaier G, Gross T, Horton-Taylor D, Klapper W, Lesa G, Marcus R, Miles RR, Nottage K et al. (2019)
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Eur J Cancer, 110, 74-85
DOI 10.1016/j.ejca.2019.01.013, PubMed 30772656
Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319
Bader P, Kuçi Z, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, von Luettichau I, Herter-Sprie G, Uddin MA, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J, Salzmann-Manrique E, Hutter M, Schäfer R, Seifried E, Klingebiel T, Bonig H et al. (2018)
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
Bone Marrow Transplant, 53 (7), 852-862
DOI 10.1038/s41409-018-0102-z, PubMed 29379171
Buechner J, Kersten MJ, Fuchs M, Salmon F, Jäger U (2018)
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe
Hemasphere, 2 (1), e18
DOI 10.1097/HS9.0000000000000018, PubMed 31723747
Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
Bone Marrow Transplant, 53 (5), 657-660
DOI 10.1038/s41409-018-0091-y, PubMed 29358600
Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT et al. (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
N Engl J Med, 378 (5), 439-448
DOI 10.1056/NEJMoa1709866, PubMed 29385370
Orlando EJ, Han X, Tribouley C, Wood PA, Leary RJ, Riester M, Levine JE, Qayed M, Grupp SA, Boyer M, De Moerloose B, Nemecek ER, Bittencourt H, Hiramatsu H, Buechner J, Davies SM, Verneris MR, Nguyen K, Brogdon JL, Bitter H, Morrissey M, Pierog P, Pantano S, Engelman JA, Winckler W (2018)
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Nat Med, 24 (10), 1504-1506
DOI 10.1038/s41591-018-0146-z, PubMed 30275569
Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A et al. (2017)
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
J Allergy Clin Immunol, 141 (1), 322-328.e10
DOI 10.1016/j.jaci.2017.02.036, PubMed 28392333
Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Dürken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Frühwald MC (2016)
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007
Cancer Med, 5 (8), 1765-75
DOI 10.1002/cam4.741, PubMed 27228363
Panagopoulos I, Micci F, Thorsen J, Haugom L, Buechner J, Kerndrup G, Tierens A, Zeller B, Heim S (2013)
Fusion of ZMYND8 and RELA genes in acute erythroid leukemia
PLoS One, 8 (5), e63663
DOI 10.1371/journal.pone.0063663, PubMed 23667654
Buechner J, Einvik C (2012)
N-myc and noncoding RNAs in neuroblastoma
Mol Cancer Res, 10 (10), 1243-53
DOI 10.1158/1541-7786.MCR-12-0244, PubMed 22936790
Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B, Einvik C (2011)
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
Carcinogenesis, 32 (7), 1005-12
DOI 10.1093/carcin/bgr073, PubMed 21572098
Henriksen JR, Buechner J, Løkke C, Flægstad T, Einvik C (2011)
Inhibition of gene function in mammalian cells using short-hairpin RNA (shRNA)
Methods Mol Biol, 703, 189-204
DOI 10.1007/978-1-59745-248-9_13, PubMed 21125491
Henriksen JR, Haug BH, Buechner J, Tømte E, Løkke C, Flaegstad T, Einvik C (2011)
Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
BMC Dev Biol, 11, 1
DOI 10.1186/1471-213X-11-1, PubMed 21194500
Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C (2010)
Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells
Differentiation, 81 (1), 25-34
DOI 10.1016/j.diff.2010.09.184, PubMed 20980091
Kranendijk M, Struys EA, Gibson KM, Wickenhagen WV, Abdenur JE, Buechner J, Christensen E, de Kremer RD, Errami A, Gissen P, Gradowska W, Hobson E, Islam L, Korman SH, Kurczynski T, Maranda B, Meli C, Rizzo C, Sansaricq C, Trefz FK, Webster R, Jakobs C, Salomons GS (2010)
Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria
Hum Mutat, 31 (3), 279-83
DOI 10.1002/humu.21186, PubMed 20020533
Berg T, Kalsaas AH, Buechner J, Busund LT (2009)
Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript
Cancer Genet Cytogenet, 194 (1), 53-7
DOI 10.1016/j.cancergencyto.2009.06.002, PubMed 19737655
Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hählen K, Hasle H, Licht JD, Gelb BD (2003)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Nat Genet, 34 (2), 148-50
DOI 10.1038/ng1156, PubMed 12717436
